TIME Names Handheld OrCam Read Device to 100 Best Inventions of 2021 List
Jerusalem based OrCam Technologies, a global leader in personal, empowering AI-driven tech innovations, announced that OrCam Read, a first-of-its-kind, the handheld digital reader that instantly
Nanox New X-ray Machine Could Allow Fast Diagnosis of COVID Pneumonia
Nanox, an Israeli corporation that has developed the first solid state digital X-ray source designed to be used in real-world medical imaging applications, has partnered
BiondVax teams up with Max Planck Society on developing VHH antibodies against COVID-19
BiondVax signed an agreement for a broad-based strategic collaboration with the Max Planck Society (MPG) and University Medical Center Göttingen (UMG), Germany. This 5-year strategic
Jerusalem based Salignostics Launches World’s 1st Saliva Pregnancy Test
Salignostics, an Israeli medical startup, https://www.salignostics.com/ is launching the world’s first pregnancy test that delivers results from saliva samples, the SaliStick, using technology it developed
RenalSense raises $14M Series A Funding to Bolster Global Product Line Commercialization and Expansion
RenalSense™, a leader in real-time renal diagnostics, has secured $14M to bolster the global commercialization of its current product, the Clarity RMS, expand clinical validation
IllumigynTM Raises $33M to Provide Women with Outstanding, Accessible, & Affordable Gynecological Care Worldwide
illumigyn , the world’s first remote gynecological imaging platform, has raised $33M following the closure of its latest investment round. This current investment round includes
Mirror Biologics Issued US Patent Covering Next Gen Therapeutic Vaccine Technology for Cancer & Infectious Disease Treatment
Mirror Biologics, Inc., received a US Patent No. 11,160,852 on the “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of
Oramed’s Oravax Oral COVID-19 Vaccine to Begin Phase 1 Clinical Trial
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed,com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that its majority-owned
Alpha TAU Enrolls Its First Patient in Combination Trial of Alpha DaRT™ & Pembrolizumab (Keytruda)
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, has enrolled its first patient in the combination study of Alpha
